Showing results (41-50 of 80) with videos related to
Sort By:
Pageof 8
The Journal of Clinical Investigation|April 15, 2021
TYRO3 induces anti-PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosisZhou Jiang, Seung-Oe Lim, Meisi Yan, et al.Cancer Research|April 17, 2008
Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinomaChia-Jui Yen, Julie G Izzo, Dung-Fang Lee, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2017
PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated ImmunosuppressionShiping Jiao, Weiya Xia, Hirohito Yamaguchi, et al.American Journal of Translational Research|August 18, 2015
Phosphorylation of EZH2 at T416 by CDK2 contributes to the malignancy of triple negative breast cancersCheng-Chieh Yang, Adam LaBaff, Yongkun Wei, et al.Oncotarget|August 6, 2016
GSK3β inactivation promotes the oncogenic functions of EZH2 and enhances methylation of H3K27 in human breast cancersHow-Wen Ko, Heng-Huan Lee, Longfei Huo, et al.The Journal of Clinical Investigation|November 9, 2013
KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signalingKlaus W Wagner, Hunain Alam, Shilpa S Dhar, et al.Nature Cell Biology|January 12, 2016
The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancerAifu Lin, Chunlai Li, Zhen Xing, et al.Biorxiv : the Preprint Server for Biology|October 4, 2023
KRAS inhibition activates an actionable CD24 'don't eat me' signal in pancreas cancerYongkun Wei, Minghui Liu, Er-Yen Yen, et al.Molecular Cell|December 27, 2011
IKKα activation of NOTCH links tumorigenesis via FOXA2 suppressionMo Liu, Dung-Fang Lee, Chun-Te Chen, et al.Cell Reports. Medicine|February 18, 2026
Syndecan-1-targeted therapeutic antibody impairs macropinocytosis and elicits antitumor immunity in pancreatic cancerZecheng Yang, Madelaine S Theardy, Shuaitong Chen, et al.Pageof 8